The biological role of the Fas/FasL system during tumor formation and progression.
about
Synergistic Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Microenvironment and Cancer CellsNatural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer ImmunotherapyAssociation of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studiesFAS-1377 G/A (rs2234767) polymorphism and cancer susceptibility: a meta-analysis of 17,858 cases and 24,311 controlsRole of exosomes in immune regulationAssociations between FAS rs2234767 and FASL rs763110 polymorphisms and the risk of lung cancer: a meta-analysis of 39,736 subjectsFas Ag-FasL coupling leads to ERK1/2-mediated proliferation of gastric mucosal cellsEstrogens up-regulate the Fas/FasL apoptotic pathway in lactotropesFAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck.Fas/FasL interaction of nucleus pulposus and cancer cells with the activation of caspases.Glycyrrhetinic Acid inhibits cell growth and induces apoptosis in ovarian cancer a2780 cellsAlpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cellsThe Expression and Prognostic Impact of CD95 Death Receptor and CD20, CD34 and CD44 Differentiation Markers in Pediatric Acute Lymphoblastic LeukemiaFas palmitoylation by the palmitoyl acyltransferase DHHC7 regulates Fas stability.Fas receptor (CD95) & Fas ligand (CD178) expression in patients with tobacco-related intraoral squamous cell carcinoma.Piwil2 inhibits keratin 8 degradation through promoting p38-induced phosphorylation to resist Fas-mediated apoptosisDestination 'lysosome': a target organelle for tumour cell killing?HCMV infection: modulating the cell cycle and cell death.Immunotherapy and immunoselection -- tumour escape as the final hurdle.Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neckApoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.Quantitative assessment of the association between Fas/FasL gene polymorphism and susceptibility to esophageal carcinoma in a north Chinese population.Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese females.FAS/FASL gene polymorphisms in Turkish patients with chronic myeloproliferative disordersRequirement of inositol 1,4,5-trisphosphate receptors for tumor-mediated lymphocyte apoptosis.Lipid rafts and raft-mediated supramolecular entities in the regulation of CD95 death receptor apoptotic signaling.Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes.Investigation of gallic acid induced anticancer effect in human breast carcinoma MCF-7 cells.DNA-damaging drug-induced apoptosis sensitized by N-myc in neuroblastoma cells.CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells.A biochemical mechanism for resistance of intervertebral discs to metastatic cancer: Fas ligand produced by disc cells induces apoptotic cell death of cancer cells.CD95 ligand mediates T-cell receptor-induced apoptosis of a CD4+ CD8+ double positive thymic lymphoma.Adenovirus-mediated FasL gene transfer into human gastric carcinoma.Anti-gastric cancer active immunity induced by FasL/B7-1 gene-modified tumor cellsDose- and time-dependent effect of high glucose concentration on viability of notochordal cells and expression of matrix degrading and fibrotic enzymesGlycyrrhetinic Acid Induces Apoptosis in Leukemic HL60 Cells Through Upregulating of CD95/ CD178.Polymorphisms of the FAS and FASL genes and risk of breast cancer.Molecular cloning, functional characterization and phylogenetic analysis of TRAIL in Japanese pufferfish Takifugu rubripes.Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.Interplay of Viral Infection, Host Cell Factors and Tumor Microenvironment in the Pathogenesis of Nasopharyngeal Carcinoma.
P2860
Q26752653-86AF7A3C-C5DD-4234-96E4-2BC51770EC85Q26772347-B6E81F55-A612-4A02-91C9-2AF1BA2A8E78Q26859155-B34900B9-35B7-4020-ADAE-BDFF467345FAQ26866492-A1F5FCE0-D7D0-4F78-91DE-D10DC250493DQ28248090-76769C18-B196-43D9-8985-F78496225A7DQ28391896-BD21ABD8-AAB0-486F-8FB7-D9C7AB2B5AEFQ28566013-67550DB5-CF22-4769-8DE9-D2A4E239BEDEQ28578235-87994B5A-5AC4-42FE-8304-7826826D95A3Q33903227-ECD25A26-B859-4C0F-BC41-38DDA4F14DC0Q33969742-87908436-1E4D-4B4A-A5C5-15C26F7B1A5BQ34424411-D428FBCC-D11A-4C13-AC95-0BECE2931289Q35010607-B550DCBC-5FBB-47BC-9FAD-2DBCEE8C126FQ35118521-B487D1FB-267C-4C39-A536-BFC06421AAB2Q35167590-931DB2BF-7BED-4800-B408-7729CC0FEBF8Q35210153-13D831EB-E003-4A00-8DF3-65BF7465596EQ35280852-A85FE26D-BA37-4740-8ACE-6BFAF1B8B7EAQ35549436-BD9CDBED-A2E2-4C15-8224-678E4568DDD5Q35613805-8BA0ABEE-2EBD-4F09-8114-5E06D2E723E4Q35785852-B68FD745-50F3-46F4-B45B-5399B5D64452Q35917835-0420B21D-BF72-4C26-8D5B-002E9E41DBF0Q36075038-439A1819-CD9D-46D2-98CE-A189E4471032Q36797318-6469592D-1004-43D6-947A-3E0EAA101201Q37138359-F47BBAD2-2BFF-4372-A3D0-39CB7690713EQ37675522-5760FD78-B3FF-4779-9B03-3BE04BD0D6B7Q38291229-753856EC-58C6-473D-872B-E07E7B3F311DQ38363543-849DA446-58BE-4647-B4F2-6F033C03652AQ38560697-85B971DB-2029-41B0-9313-B400DD165181Q38991248-904F9A2A-412C-4C7E-87C1-ED9A54F4E62FQ39471884-D014F8F9-2FCE-4BA3-9D3B-73F0297DD6D2Q39959143-869857E1-69C0-4C13-9241-4D639D4F5009Q40096819-7A254726-4E22-446A-AB63-F224163A7BF5Q40269059-CE5896E6-8EB5-4053-9BE2-B94D2E7B76E2Q40411306-24BFA520-EBBC-4D64-98BC-1AFC6C3B23E4Q40414746-E473FDB1-6335-482D-915D-CFCC33A180F1Q41046146-D634B85B-3090-4792-8B10-21E244A2EDF6Q41506622-091E4480-BA5F-49B8-847D-71ED4D3A1B66Q41811141-8F5FB8A5-7863-4460-B828-12AF21516010Q42614883-7EE5FC5E-B457-456F-8A66-9A3D1AA1123BQ47230945-7C3F5B49-F35A-4884-AE7A-16CCD161CE21Q55313422-EF013458-0EA8-46A1-9B31-303A687F2DF6
P2860
The biological role of the Fas/FasL system during tumor formation and progression.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The biological role of the Fas/FasL system during tumor formation and progression.
@ast
The biological role of the Fas/FasL system during tumor formation and progression.
@en
The biological role of the Fas/FasL system during tumor formation and progression.
@nl
type
label
The biological role of the Fas/FasL system during tumor formation and progression.
@ast
The biological role of the Fas/FasL system during tumor formation and progression.
@en
The biological role of the Fas/FasL system during tumor formation and progression.
@nl
prefLabel
The biological role of the Fas/FasL system during tumor formation and progression.
@ast
The biological role of the Fas/FasL system during tumor formation and progression.
@en
The biological role of the Fas/FasL system during tumor formation and progression.
@nl
P1476
The biological role of the Fas/FasL system during tumor formation and progression.
@en
P2093
Ernst Reichmann
P304
P356
10.1016/S1044-579X(02)00017-2
P577
2002-08-01T00:00:00Z